ArticleMolecular therapy. Methods & clinical development2021

miR-223-3p and miR-24-3p as novel serum-based biomarkers for myotonic dystrophy type 1.

Demetris Koutalianos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.